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Summary
A consanguineous family affected by an autosomal re-
cessive, progressive neurodegenerative Huntington-like
disorder, was tested to rule out juvenile-onset Hunt-
ington disease (JHD). The disease manifests at ∼3–4
years and is characterized by both pyramidal and ex-
trapyramidal abnormalities, including chorea, dystonia,
ataxia, gait instability, spasticity, seizures, mutism, and
intellectual impairment. Brain magnetic resonance im-
aging (MRI) findings include progressive frontal cortical
atrophy and bilateral caudate atrophy. Huntington CAG
trinucleotide-repeat analyses ruled out JHD, since all af-
fected individuals had repeat numbers within the normal
range. The presence of only four recombinant events
( ) between the disease and the Huntington locusv = .2
in 20 informative meioses suggested that the disease lo-
calized to chromosome 4. Linkage was initially achieved
with marker D4S2366 at 4p15.3 (LOD 3.03). High-
density mapping at the linked locus resulted in homo-
zygosity for markers D4S431 and D4S394, which span
a 3-cM region. A maximum LOD score of 4.71 in the
homozygous interval was obtained. Heterozygosity at
the distal D4S2366 and proximal D4S2983 markers de-
fines the maximum localization interval (7 cM). Multiple
brain-related expressed sequence tags (ESTs) with no
known disease association exist in the linkage interval.
Among the three known genes residing in the linked
interval (ACOX3, DRD5, QDPR), the most likely can-
didate, DRD5, encoding the dopamine receptor D5, was
excluded, since all five affected family members were
heterozygous for an intragenic dinucleotide repeat. The
inheritance pattern and unique localization to 4p15.3
are consistent with the identification of a novel, auto-
somal recessive, neurodegenerative Huntington-like
disorder.
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Introduction
A nuclear family with five members affected by an early
onset (3–4 years), apparently autosomal recessive, neu-
rodegenerative disorder resembling juvenile-onset
Huntington disease (JHD [MIM 143100]) was referred
for DNA testing to rule out JHD. JHD manifests be-
tween the first and fourth years of life (Farrer and Con-
neally 1985; van Dijk et al. 1986) and presents with an
atypical Huntington clinical picture characterized by
Parkinsonism, dystonia, seizures, and pyramidal abnor-
malities in association with progressive dementia (van
Dijk et al. 1986). Phenocopies of HD have been de-
scribed in the literature and have been grouped as a
unique OMIM entry (Huntington-disease-like neurod-
egenerative disorder [MIM 603218]). In a cohort study
of 1,022 individuals with Huntington-like features (An-
drew et al. 1994), 12 patients did not show an expanded
CAG repeat in the HD locus. In at least four cases, family
studies excluded 4p16.3 (HD region) as the locus re-
sponsible for the phenotype. Mutations in the HD gene
other than CAG expansion were not excluded for the
remaining eight cases. However, in as many as seven of
these cases, retrospective review of their clinical features
identified characteristics not typical of HD. The inves-
tigators speculated that on rare occasions mutations in
other, as-yet-undefined genes can present with a clinical
phenotype very similar to that of HD. Xiang et al. (1998)
investigated a family with a late-onset autosomal dom-
inant (affected members were observed in three gener-
ations of the family) Huntington-like disorder without
CAG-repeat expansion in the HD gene. The chromo-
some 4p region was excluded by linkage analysis. The
disease gene was then mapped to chromosome 20p
(LOD 3.01 for marker D20S482) in a 2.7-cM region
between the markers D20S193 and D20S895.
The family referred for DNA testing consists of 12
individuals: parents who are healthy first cousins in the
sixth decade of life, and five normal and five affected
siblings. The disease is characterized by both pyramidal
and extrapyramidal abnormalities, including chorea,
dystonia, ataxia, gait instability, spasticity, seizures,mut-
ism, and intellectual impairment. Despite the fact that
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the mode of inheritance was clearly not autosomal dom-
inant, Huntington CAG-repeat analysis was performed,
because the phenotype of affected individuals resembled
that of JHD. The disease was ruled out, since the
Huntington locus CAG-repeat numbers were within the
normal range for all affected individuals. Four affected
and one normal sibling were homozygous for 18 CAG
repeats, whereas one affected and four normal siblings
were homozygous for 16 CAG repeats. Both parents
were heterozygotes for 16 and 18 CAG repeats. The
presence of only four recombinant events between the
disease and the Huntington locus from 20 informative
meioses ( ) in this family suggested that the diseasev = .2
may localize to chromosome 4. Thus, genotyping and
linkage analyses were performed with microsatellite
markers spanning the entire chromosome 4.
Subjects and Methods
Clinical Description
The nuclear family consists of 12 individuals: the par-
ents (III:2 and III:3), who are healthy first cousins, and
a sibship of ten (fig. 1). The order of birth of affected
and unaffected siblings is: IV:10, IV:6, IV:7, IV:8, IV:3,
IV:1, IV:2, IV:9, IV:4, and IV:5. Five of the children are
healthy unaffected individuals, whereas the other five are
affected by a neurodegenerative disorder as follows:
Individual IV:1.—A 21-year-old man. He had normal
early developmental milestones with the exception of
speech delay. At age 5 years, his speech became pro-
gressively incoherent, hand movements became clumsy,
and his mobility was disturbed. He developed both rapid
and slow involuntary movements of all limbs and trunk
with deforming postures. By age 12 years, he became
mute and wheel-chair bound and developed seizures and
brief episodes of tonic-clonic movements of upper limbs
with up-rolling of both eyes. At present, he is fully de-
pendent. He is severely emaciated with diffused muscle
contractures and absent orminimal voluntarymovement
of upper and lower extremities. He is alert, responding
to verbal stimuli with localized full eye movements, but
has limited head movement. His facial expression is poor
but symmetric, and his muscle tone is increased. Brain
computerized tomography (CT) and MRI studies
showed generalized frontal cortical atrophy and bilateral
caudate nuclei atrophy. Results of single-photon emis-
sion computerized tomography (SPECT) were normal.
Individuals IV:2 and IV:3.—A 19-year-old man and a
24-year-old woman. Both are bedridden and fully de-
pendent. The clinical picture, including age at onset and
course of disease, was similar to that of their aforemen-
tioned brother (individual IV:1).
Individual IV:4.—A 14-year-old girl. At age 4 years
she started showing mobility and speech disturbances.
At age 8 years, she started having seizures and frequent
brief episodes of generalized tonic movements, with flex-
ion, crossing of both upper limbs, and extension of lower
limbs. At present, she responds to simple commands
with incoherent speech, excessive inappropriate shout-
ing, and crying or laughter. She frequently displays cho-
reoathetoid movements with variable limb and trunk
abnormal posturing. She also exhibits rigidity with slow
and awkward movements, and she is doubly incontinent.
Individual IV:5.—A 12-year-old girl with progressive
deterioration of speech and mobility commencing at age
3–4 years. At age 9 years she became totally mute and
incontinent, walked only with help, and needed assis-
tance in feeding. There was early onset of abnormal
choreiform movements. At present, she is emaciated and
responds poorly to simple orders with poor facial ex-
pressions but full eye movements. She is able to move
all limbs voluntarily, but only slowly, and with gener-
alized rigidity. Apart from a wide-based gait, there is no
evidence of cerebellar dysfunction.
Investigation
Investigations were performed to rule out various dif-
ferential diagnoses. All patients had normal complete
blood counts, blood film, renal, and liver-function tests,
normal levels of serum and 24-h urine copper, serum
ceruloplasmin, and normal findings from slit-lamp
examinations. Electroencephalogram (EEG) results
showed increased fast activity only. Nerve conduction
and both visual and auditory evoked potentials were
within normal limits. Screening for metabolic disorders
and karyotypes gave normal findings.
Isolation and PCR Amplification of Genomic DNA
Peripheral blood samples were collected for genotyp-
ing from all 12 individuals in the nuclear family (parents,
five affected individuals, and five normal individuals).
Appropriate informed consent was obtained from the
family for this study, and the study was approved by the
King Faisal Specialist Hospital and Research Center’s
internal review board (Research Ethics Committee). All
work was performed at the Research Center of King
Faisal Hospital and Research Center. High-molecular-
weight genomic DNA was extracted by use of standard
salt-precipitation methods (Kendall et al. 1991). Ge-
nomic DNA (100 ng) was amplified in a 20-ml reaction
mixture containing 50 mM KCl, 10 mM Tris-HCl (pH
9.0), 1.5 mMMgCl2, 0.1%Triton X-100, 0.25mMeach
dNTP, 20 pM each primer, and 0.5 U Taq polymerase
(Pharmacia). The amplification consisted of an initial
denaturation of 5 min at 95C followed by 40 cycles of
denaturation at 94C for 1 min, annealing for 1 min
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Figure 1 Pedigree of an inbred family affected with a novel neurodegenerative Huntington-like disorder. Double marriage lines indicate
consanguineous marriages. Genotypes for seven DNA markers from chromosome 4p15.3 are shown. Regions of autozygosity are enclosed by
a rectangle. The actual order of birth of affected and unaffected individuals is: IV:10, IV:6, IV:7, IV:8, IV:3, IV:1, IV:2, IV:9, IV:4, and IV:5.
(58C for cycles 1–5, 54C for cycles 6–10, 50C for
cycles 11–15, and, finally, 54C for the remaining 25
cycles). Extension was at 72C for 2 min in all cycles.
Amplification was terminated after a single incubation
at 72C for 5 min.
Genotyping
A low-resolution (15–20 cM) scan of chromosome 4
was performed with nine fluorescently labeled primer
sets from the Cooperative Human Linkage Center
(CHLC) marker set for markers D4S2366, D4S2632,
D4S2368, D4S1627, D4S3248, D4S2367, D4S2623,
D4S1629, and D4S1652 as well as the Huntington CAG
trinucleotide repeat (Bond and Hodes 1996). A high-
resolution scan of the 4p15 region was performed with
fluorescently labeled primers sets from the Ge´ne´thon
Chromosome 4 map for markers D4S412, D4S3023,
D4S2366, D4S431, D4S394, D4S2983, and D4S1599.
Analysis was also performed for an intragenic dinucle-
otide repeat at theDRD5 locus (Sherrington et al. 1993).
Alleles were separated after amplification by electro-
phoresis in 1# Tris-Borate-EDTA, 6% denaturing poly-
acrylamide gel on an ABI 373A automated sequencer,
as recommended by the manufacturer. Data collection
and analysis were done with GeneScan 672 software (PE
Biosystems).
Statistical Analysis
Multipoint parametric linkage analysis was performed
with GeneHunter (Kruglyak et al. 1996) and Map-
Maker/Homoz (Kruglyak et al. 1995) linkage-analysis
software. A 50%-penetrant autosomal recessive trait
was assumed, and a disease-gene frequency of .0001 was
used (appropriate for a very rare disease). Equal recom-
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Table 1
Multipoint Linkage Analysis for the
Disease Locus and 10 Microsatellite
Markers Spanning Chromosome 4 at
15–20 cM Intervals with GeneHunter
Marker
Distance
(KcM) Maximum LOD
HD .00 10,000
3.57 .88
7.13 1.78
10.70 2.31
14.27 2.71
D4S2366 17.83 3.03
21.40 2.71
24.97 2.31
28.53 1.77
32.10 .87
D4S2632 35.67 10,000
39.23 1.13
42.80 .63
46.37 .64
49.93 1.16
D4S2368 53.50 10,000
57.07 1.76
60.63 1.38
64.20 1.55
67.77 2.37
D4S1627 71.33 10,000
74.90 4.72
78.47 3.91
82.04 3.73
85.60 4.12
D4S3248 89.17 10,000
92.74 4.31
96.30 4.16
99.87 4.68
103.44 6.08
D4S2367 107.00 10,000
110.57 4.04
114.14 3.01
117.70 2.79
121.27 3.32
D4S2623 124.84 10,000
128.40 3.27
131.97 2.65
135.54 2.78
139.10 3.73
D4S1629 142.67 10,000
146.24 5.04
149.80 4.19
153.37 4.21
156.94 5.04
D4S1652 160.50 10,000
bination frequencies between males and females were
assumed. Linkage analyses were done with allele fre-
quencies estimated by parental data and with equal allele
frequencies for all microsatellite markers. Identical re-
sults were obtained with the data sets.
Results
Analysis of the Huntington CAG trinucleotide repeat
showed only two alleles (16 and 18 CAG repeats) in
this family. Both parents were heterozygous (16/18 re-
peats). Four affected and one normal individual were
homozygous for 18 repeats, whereas one affected and
four normal siblings were homozygous for 16 repeats.
JHD was thus excluded, because the Huntington CAG-
repeat number was within the normal range (!27 re-
peats) for all affected individuals in this family.
A low-resolution scan of chromosome 4 was per-
formed with 10 equally spaced (15–20 cM) fluorescently
labeled microsatellite markers spanning the entire chro-
mosome. All 12 individuals in the sibship were geno-
typed (fig. 1). Linkage analysis with GeneHunter re-
sulted in a maximum LOD score of 3.03 with marker
D4S2366 atHsa 4p15.3 (table 1). High-densitymapping
at the linked locus was performed with seven fluores-
cently labeled microsatellite markers localizing at 4p15.3
(fig. 1). Multipoint parametric linkage analysis was per-
formed by assuming a 50%-penetrant autosomal reces-
sive trait and a disease gene frequency of .0001. The
analysis resulted in a maximum LOD score of 3.03 (fig.
1b) for four perfectly linked markers (D4S2366,
D4S431, D4S394, and D4S2983). Homozygosity was
observed in all affected individuals for markers D4S431
and D4S394, which spanned a 3-cM region (fig. 1). A
maximum LOD score of 4.71 in the homozygous inter-
val was obtained by both GeneHunter and MapMaker/
Homoz linkage analysis software (table 2, fig. 2a). Het-
erozygosity at the distal D4S2366 and proximal
D4S2983 markers define a 7-cM interval within which
the disease localizes (fig. 2b).
Analysis of an intragenic dinucleotide repeat in the
DRD5 gene (a likely candidate) showed four alleles (1,
2, 3, and 4 ) in this family. All affected individuals were
heterozygotes (1/2). Paternal and maternal genotypes
were 2/4 and 1/3, respectively. Alleles in the unaffected
individuals were: 3/4 for IV:6, 2/3 for IV:7, 1/4 for IV:
8, 3/4 for IV:9, and 2/3 for IV:10.
Discussion
This family is afflicted by an early-onset, progressive,
neurodegenerative Huntington-like disorder, manifest-
ing with both pyramidal and extrapyramidal abnor-
malities that include choreoathetosis, ataxia, dystonia,
seizures, spasticity, mutism, and generalized intellectual
impairment. All evidence indicates that inheritance for
this disease is autosomal recessive. The disorder mani-
fests in all affected individuals very early, at age 3–4
years, with a striking phenotype. Both male and female
individuals are affected. The parents are first cousins,
and both are healthy individuals late in the sixth decade
Figure 2 a, Multipoint linkage analyses for seven 4p15 markers with GeneHunter. Genetic distances and LOD scores are indicated.
Marker order and distances are indicated. b, Chromosome 4 cytogenetic and linkage maps in the 4p16-15 region. Markers used for linkage
analysis are highlighted.
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Table 2
Homozygosity Multipoint Linkage
Analysis for the Disease Locus
and Markers D4S431 and D4S394
Spanning a 3-cM Region at
4p15.3 with GeneHunter
Marker
Distance
(KcM)
Maximum
LOD
D4S2366 .00 3.03
D4S431 2.00 4.71
2.62 4.71
3.24 4.71
3.86 4.71
4.48 4.71
D4S394 5.09 4.71
D4S2983 7.09 3.03
of life. In addition, information exists that first cousins
of the affected individuals (whose parents are also first
cousins) are reportedly affected by a “debilitating neu-
rological disorder,” although examination, evaluation,
and genotyping of these individuals was not possible.
Although the affected individuals in this family represent
50% of the sibship size—instead of the 25% expected
for an autosomal recessive disorder—each pregnancy is
an independent event, and the number of affected in-
dividuals in this sibship is possible.
The disease gene was localized to a 3-cM homozygous
region at 4p15.3 with markers D4S431 and D4S394
(max LOD score 4.71). Heterozygosity at the distal
D4S2366 and proximal D4S2983 markers define the
maximum localization interval (7 cM). Despite the con-
sanguineous marriage, it appears that four distinct chro-
mosomal domains exist in the 4p region defining the
linkage interval. This implies either that the disease al-
lele-bearing chromosomes are relatively old in the family
or that they do not all originate within this small group.
The four distinct chromosomal domains at 4p could be
accounted for by the presence of a “hot-spot” for re-
combination in the 4p region between markers D4S10
and D4S125 (spanning ∼8 cM) immediately adjacent
(distal) to the disease linkage interval (Bates et al. 1991).
Two of the markers used for the high-density mapping
(D4S412 and D4S3023) fall within the “hot-spot” and
both show recombinant events in affected (IV:2) as well
as in normal (IV:7 and IV:9) individuals. Thus, the pres-
ence of this recombination “hot-spot” is a possible ex-
planation for both the limited region of homozygosity
(confined between markers D4S431 and D4S394, a 3-
cM interval) shared among the affected individuals and
the appearance of four distinct chromosomal domains
in the 4p region.
There are a number of known inherited disorders that
map in the general 4p15-4pter region. These include:
phenylketonuria II (DHQR), achondroplasia (FGFR-3),
congenital stationary nightblindness 3 (PDE6B), mu-
copolysaccharidosis I (MPS I), Huntington disease (HD),
Wolf-Hirschhorn syndrome (WHS), Ellis-van Creveld
syndrome (EVC), diabetes mellitus and insipidus with
optic atrophy, and deafness (a nuclear gene that predis-
poses to multiple mitochondrial DNA deletions in fam-
ilies with Wolfram syndrome [MIM 222300]). Among
all, the only disease with clinical similarities to the novel
disorder described here is, of course, Huntington disease.
There are multiple brain-related ESTs with no known
disease association in the linkage interval (between
markers D4S2366 and D4S2983). Although ∼200 genes
are expected to map within this interval, only three
known genes have been mapped in the 4p15.3 region.
These are: quinone dihydropteridine reductase (QDPR;
Brown and Dahl 1987), pristanoyl acyl-coenzyme A
oxidase 3 (ACOX3; Vanhooren et al. 1997), and do-
pamine receptor D5 (DRD5; Eubanks et al. 1992).
QDPR was excluded as a candidate, since defects in the
gene cause phenylketonuria through dihydropteridine
reductase deficiency in affected individuals (Smooker et
al. 1995).
The ACOX3 gene product (pristanoyl-CoA oxidase)
plays a role in desaturation of 2-methyl branched-chain
fatty acids and the bile–acid intermediates di- and tri-
hydroxycoprostanic acids. The gene is expressed to such
a low extent in liver that its mRNA cannot be detected
by Northern-blot analysis (Vanhooren et al. 1996), and
its product is undetected by immunoblotting or by en-
zyme-activity measurements (Van Veldhoven et al.
1994). Screening the ACOX3 gene for sequence alter-
ations in patients with elevated pristanic-acid levels (af-
fected by generalized peroxisomal disorders) did not
identify any mutations (R. J. A. Wanders, personal com-
munication). Thus, the ACOX3 gene is an unlikely can-
didate but cannot be entirely excluded.
The human D5 dopamine receptor (DRD5 [MIM
126453]) stimulates biphasic intracellular accumulation
of cAMP (adenylate-cyclase activity) (Grandy et al.
1991). Sherrington et al. (1993) cloned the DRD5 re-
ceptor and used it to map the DRD5 gene by linkage
studies in 39 Centre d’E´tudes du Polymorphisme Hu-
main (CEPH) pedigrees to 4p15.3. Tissue in situ hy-
bridization studies have shown that DRD5 is neuron
specific and localizes in limbic regions of the brain. Beis-
chlag et al. (1995) determined that DRD5 mRNA is
most abundant in discrete cortical areas (layers II, IV,
and VI), the dentate gyrus, and hippocampal subfields
but is expressed at very low levels in the striatum. In
addition, DRD5 mRNA antisense riboprobes label dis-
crete cell bodies in the pars compacta of the substantia
nigra.
DRD5 was initially considered a likely candidate gene
because it maps in the linkage interval, and alterations
in the various subtypes of dopamine receptors have been
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associated with chorea, dystonia, and rigidity (Wich-
mann and DeLong 1997)—all part of the clinical pre-
sentation of this novel Huntington-like syndrome. The
five affected individuals were genotyped for a DRD5
intragenic dinucleotide repeat, and all were heterozy-
gous. Because homozygosity by descent at the affected
locus is expected, heterozygosity renders DRD5 a less
likely candidate. Heterozygosity at DRD5 defines the
proximal boundary of the linkage interval. DRD5 can
not be excluded as a candidate on the basis of hetero-
zygosity for the intragenic dinucleotide repeat if an au-
tosomal dominant pattern of inheritance for this dis-
order is to be considered. The high rate of affected
siblings (50%) in the sibship is consistent with autoso-
mal dominant inheritance. Because it was impossible to
confirm the presence of the disease in the affected cousins
by clinical examination, there could be a slight chance
that the disease is inherited as an autosomal dominant
trait associated with germline mosaicism in one of the
parents. In that case, DRD5 would remain a likely can-
didate gene. However, the inferred haplotypes of the
unaffected individuals (fig. 1) do not support this
concept.
At present, cloning of the gene cannot be attempted,
because of the size of the linkage interval (6–7 cM) and
the small number of affected individuals (five). Identi-
fication of additional affected families would allow nar-
rowing of the linkage interval, which, in turn, might
facilitate physical mapping for identification and cloning
of the offending gene. It is possible that some of the
Huntington-like cases described by Andrew et al. (1994)
(which had no expansion in the HuntingtonCAG repeat,
but in which linkage to the distal 4p region could not
be excluded) represent additional patients with this
novel disease.
The similarity in clinical symptomatology of this novel
disease and HD may indicate a common pathogenesis.
The identification of the defective gene and its product
causing this novel disorder promises to elucidate the mo-
lecular mechanism underlying this particular basal-gan-
glia neurodegenerative disease and, potentially, others.
In summary, the inheritance pattern and unique locali-
zation to 4p15.3 for this Huntington-like disease are
consistent with the identification of a novel, autosomal
recessive neurodegenerative disorder.
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